Metropolitan Life Insurance Company (MetLife)’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-150,333
Closed -$12.1M 2597
2016
Q4
$12.1M Sell
150,333
-4,443
-3% -$353K 0.09% 220
2016
Q3
$12.3M Sell
154,776
-1,343
-0.9% -$108K 0.09% 212
2016
Q2
$12.2M Buy
156,119
+318
+0.2% +$22.7K 0.09% 217
2016
Q1
$8.57M Sell
155,801
-2,168
-1% -$118K 0.07% 277
2015
Q4
$9.76M Sell
157,969
-1,555
-1% -$98.1K 0.07% 255
2015
Q3
$10.1M Sell
159,524
-1,958
-1% -$140K 0.07% 248
2015
Q2
$11.8M Sell
161,482
-1,494
-0.9% -$108K 0.08% 236
2015
Q1
$10.7M Sell
162,976
-4,515
-3% -$300K 0.08% 258
2014
Q4
$10.9M Buy
167,491
+1,414
+0.9% +$91.1K 0.08% 259
2014
Q3
$9.99M Sell
166,077
-2,363
-1% -$154K 0.07% 263
2014
Q2
$11.7M Sell
168,440
-7,566
-4% -$490K 0.08% 244
2014
Q1
$11.5M Sell
176,006
-7,392
-4% -$481K 0.08% 247
2013
Q4
$11.4M Sell
183,398
-5,269
-3% -$305K 0.08% 244
2013
Q3
$10.1M Buy
188,667
+1,037
+0.6% +$53.4K 0.08% 258
2013
Q2
$8.56M Buy
+187,630
New +$8.13M 0.07% 294

Other funds holding STJ

Metropolitan Life Insurance Company (MetLife)'s STJ Position: Q1 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 150,333 shares — an estimated $12.1M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $12.3M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 150,333 St Jude Medical shares in Q1 2017, an estimated $12.1M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s St Jude Medical position peaked at $12.3M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2017, filed 15 May 2017.